GMP LICENSED MICROBIOME THERAPEUTICS CDMO
SGS Quay Pharma is a Contract Development Manufacturing Organisation (CDMO) specialising in the development and manufacture of innovative microbiome products.
Leading Scientific Microbiome Expertise
Our in-house scientific expertise enables us to approach every project from the most fundamental principles. Delivering success to our customers during formulation development, process engineering, manufacturing, regulatory and clinical evaluation.
World-Leading Formulation Development
We create robust formulation development strategies tailored to the characteristics of each individual API with a proven track record of developing formulations containing anaerobes, bacteriophages, GMO strains, and human-derived consortia into safe, effective dosage forms.
GMP Accredited Clinical Manufacturing
SGS Quay Pharma’s expertise and GMP-accredited state-of-the-art manufacturing facilities mean that it is uniquely placed to offer fast access to clinical manufacturing and packaging for phase I, II & III clinical trials coupled with global clinical distribution logistics.